4//SEC Filing
REGENERON PHARMACEUTICALS INC 4
Accession 0001237899-15-000045
$REGNCIK 0000872589operating
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 6:14 PM ET
Size
27.1 KB
Accession
0001237899-15-000045
Insider Transaction Report
Form 4
Terifay Robert J
SVP Commercial
Transactions
- Exercise/Conversion
Common Stock
2015-08-05$30.63/sh+3,264$99,976→ 23,293 total - Sale
Common Stock
2015-08-06$587.35/sh−2,482$1,457,803→ 32,227 total - Sale
Common Stock
2015-08-06$589.76/sh−2,542$1,499,170→ 27,559 total - Sale
Common Stock
2015-08-06$592.40/sh−23$13,625→ 24,093 total - Sale
Common Stock
2015-08-06$593.66/sh−800$474,928→ 23,293 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2015-08-05−3,264→ 0 totalExercise: $30.63Exp: 2020-12-14→ Common Stock (3,264 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2015-08-05−29,236→ 0 totalExercise: $30.63Exp: 2020-12-14→ Common Stock (29,236 underlying) - Exercise/Conversion
Common Stock
2015-08-05$30.63/sh+29,236$895,499→ 52,529 total - Tax Payment
Common Stock
2015-08-05$588.64/sh−1,521$895,321→ 51,008 total - Tax Payment
Common Stock
2015-08-05$588.64/sh−14,292$8,412,843→ 36,716 total - Sale
Common Stock
2015-08-06$585.22/sh−2,007$1,174,537→ 34,709 total - Sale
Common Stock
2015-08-06$588.55/sh−2,126$1,251,257→ 30,101 total - Sale
Common Stock
2015-08-06$590.57/sh−2,486$1,468,157→ 25,073 total - Sale
Common Stock
2015-08-06$591.75/sh−957$566,305→ 24,116 total
Holdings
- 1,651(indirect: By 401(k))
Common Stock
Footnotes (7)
- [F1]Represents volume-weighted average price of sales of 2,007 shares of Company stock on August 6, 2015 at prices ranging from $584.77 to $585.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F2]Represents volume-weighted average price of sales of 2,482 shares of Company stock on August 6, 2015 at prices ranging from $587.03 to $587.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F3]Represents volume-weighted average price of sales of 2,126 shares of Company stock on August 6, 2015 at prices ranging from $588.07 to $589.00. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F4]Represents volume-weighted average price of sales of 2,542 shares of Company stock on August 6, 2015 at prices ranging from $589.12 to $590.11. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F5]Represents volume-weighted average price of sales of 2,486 shares of Company stock on August 6, 2015 at prices ranging from $590.12 to $591.09. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F6]Represents volume-weighted average price of sales of 957 shares of Company stock on August 6, 2015 at prices ranging from $591.22 to $592.00. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F7]The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS INC
CIK 0000872589
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000872589
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 6:14 PM ET
- Size
- 27.1 KB